Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Human Vaccines & Immunotherapeutics
|
March 10, 2015
CpG oligodeoxynucleotides as mucosal adjuvants
Sumiko Iho, Jun-ichi Maeyama, Fumiko Suzuki
Cancer Science
|
January 14, 2010
Glutathione S-transferase M1 inhibits dexamethasone-induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line
Naoko Hosono, Shinji Kishi, Sumiko Iho, et al.
Vaccine
|
January 26, 2023
Effect of cigarette smoke on mucosal vaccine response with activation of plasmacytoid dendritic cells: The outcomes of in vivo and in vitro experiments
Fumiko Suzuki, Jun-Ichi Maeyama, Ayumi Kubota, et al.
Journal of Leukocyte Biology
|
November 14, 2002
CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors
Rumiko Takauji, Sumiko Iho, Hisakazu Takatsuka, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 20, 2006
Collaborative action of NF-kappaB and p38 MAPK is involved in CpG DNA-induced IFN-alpha and chemokine production in human plasmacytoid dendritic cells
Youko Osawa, Sumiko Iho, Rumiko Takauji, et al.
Journal of Leukocyte Biology
|
September 10, 2003
Nicotine induces human neutrophils to produce IL-8 through the generation of peroxynitrite and subsequent activation of NF-kappaB
Sumiko Iho, Yukie Tanaka, Rumiko Takauji, et al.
Tuberculosis (Edinburgh, Scotland)
|
March 22, 2021
Evaluation of a booster tuberculosis vaccine containing mycobacterial DNA-binding protein 1 and CpG oligodeoxynucleotide G9.1 using a Guinea pig model that elicits immunity to Bacillus Calmette-Guérin
Jun-Ichi Maeyama, Sumiko Iho, Fumiko Suzuki, et al.
Vaccine
|
July 27, 2019
CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses
Koichiro Tateishi, Kohtaro Fujihashi, Norio Yamamoto, et al.
Immunity & Ageing : I & A
|
June 27, 2013
Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG
Keiichi Taniguchi, Takemasa Takii, Saburo Yamamoto, et al.
Plos One
|
March 4, 2014
A palindromic CpG-containing phosphodiester oligodeoxynucleotide as a mucosal adjuvant stimulates plasmacytoid dendritic cell-mediated T(H)1 immunity
Jun-ichi Maeyama, Hisakazu Takatsuka, Fumiko Suzuki, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Human Vaccines & Immunotherapeutics
|
March 10, 2015
CpG oligodeoxynucleotides as mucosal adjuvants
Sumiko Iho, Jun-ichi Maeyama, Fumiko Suzuki
Cancer Science
|
January 14, 2010
Glutathione S-transferase M1 inhibits dexamethasone-induced apoptosis in association with the suppression of Bim through dual mechanisms in a lymphoblastic leukemia cell line
Naoko Hosono, Shinji Kishi, Sumiko Iho, et al.
Vaccine
|
January 26, 2023
Effect of cigarette smoke on mucosal vaccine response with activation of plasmacytoid dendritic cells: The outcomes of in vivo and in vitro experiments
Fumiko Suzuki, Jun-Ichi Maeyama, Ayumi Kubota, et al.
Journal of Leukocyte Biology
|
November 14, 2002
CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors
Rumiko Takauji, Sumiko Iho, Hisakazu Takatsuka, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 20, 2006
Collaborative action of NF-kappaB and p38 MAPK is involved in CpG DNA-induced IFN-alpha and chemokine production in human plasmacytoid dendritic cells
Youko Osawa, Sumiko Iho, Rumiko Takauji, et al.
Journal of Leukocyte Biology
|
September 10, 2003
Nicotine induces human neutrophils to produce IL-8 through the generation of peroxynitrite and subsequent activation of NF-kappaB
Sumiko Iho, Yukie Tanaka, Rumiko Takauji, et al.
Tuberculosis (Edinburgh, Scotland)
|
March 22, 2021
Evaluation of a booster tuberculosis vaccine containing mycobacterial DNA-binding protein 1 and CpG oligodeoxynucleotide G9.1 using a Guinea pig model that elicits immunity to Bacillus Calmette-Guérin
Jun-Ichi Maeyama, Sumiko Iho, Fumiko Suzuki, et al.
Vaccine
|
July 27, 2019
CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses
Koichiro Tateishi, Kohtaro Fujihashi, Norio Yamamoto, et al.
Immunity & Ageing : I & A
|
June 27, 2013
Reactivation of immune responses against Mycobacterium tuberculosis by boosting with the CpG oligomer in aged mice primarily vaccinated with Mycobacterium bovis BCG
Keiichi Taniguchi, Takemasa Takii, Saburo Yamamoto, et al.
Plos One
|
March 4, 2014
A palindromic CpG-containing phosphodiester oligodeoxynucleotide as a mucosal adjuvant stimulates plasmacytoid dendritic cell-mediated T(H)1 immunity
Jun-ichi Maeyama, Hisakazu Takatsuka, Fumiko Suzuki, et al.
Page
of 2